BIOMARIN PHARMACEUTICAL INC (BMRN) Operating Lease, Payments USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Biomarin Pharmaceutical Inc annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Biomarin Pharmaceutical Inc Operating Lease, Payments for the quarter ending March 31, 2020 was $1.44 M, a 10% decline year-over-year.
  • Biomarin Pharmaceutical Inc annual Operating Lease, Payments for 2023 was $9.98 M, a 7.25% decline from 2022.
  • Biomarin Pharmaceutical Inc annual Operating Lease, Payments for 2022 was $10.8 M, a 0.9% increase from 2021.
  • Biomarin Pharmaceutical Inc annual Operating Lease, Payments for 2021 was $10.7 M, a 1.22% increase from 2020.
Operating Lease, Payments, Annual Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $9.98 M -$780 K -7.25% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $10.8 M +$96 K +0.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $10.7 M +$128 K +1.22% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-27
2020 $10.5 M +$2.35 M +28.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 $8.18 M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.